Performing ICSI using an injection pipette with the smallest possible inner diameter and a long taper increases normal fertilization rate, decreases incidence of degeneration and tripronuclear zygotes, and enhances embryo development
- PMID: 11599463
- PMCID: PMC3455505
- DOI: 10.1023/a:1016634704469
Performing ICSI using an injection pipette with the smallest possible inner diameter and a long taper increases normal fertilization rate, decreases incidence of degeneration and tripronuclear zygotes, and enhances embryo development
Abstract
Purpose: To compare the efficacy of two types of injection pipette used for ICSI, one with a larger (5-7 microns) inner diameter and a shorter taper with that inner diameter, and another with the smallest (3-5 microns) possible inner diameter and a longer taper with that inner diameter.
Methods: Retrieved oocytes at metaphase II stage were injected using one of two types of injection pipette, in 33 and 94 cycles, respectively, in a total of 127 cycles in 108 patients.
Results: In comparison to the injection pipette with a larger (5-7 microns) inner diameter and a shorter taper with that inner diameter, the injection pipette with the smallest (3-5 microns) possible inner diameter and a longer taper with that inner diameter increased normal fertilization rate ((70 +/- 3.6)% vs. (86 +/- 2.2)%; P = .001; mean +/- SEM); decreased the incidence of degeneration ((14 +/- 2.4)% vs. (5 +/- 1.4)%; P = .001) and tripronuclear zygotes ((1.0 +/- 0.35)% vs. (0.1 +/- 0.21)%; P = .03); increased Day-2 diploid embryos ((69 +/- 3.7)% vs. (85 +/- 2.2)%; P = .001) and good-quality Day-2 diploid embryos ((67 +/- 4.0)% vs. (79 +/- 2.4)%; P = .03), all per injected oocyte; and increased the number of blastomeres per good-quality Day-2 diploid embryo ((3.0 +/- 0.21 vs. 3.8 +/- 0.12; P = .0003).
Conclusions: Performing ICSI using an injection pipette with the smallest (3-5 microns) possible inner diameter and a longer taper with that inner diameter maximizes normal fertilization rate, minimizes the incidence of postinjection degeneration and tripronuclear zygotes, and enhances embryo development.
Similar articles
-
The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.Hum Reprod. 2017 Jan;32(1):119-124. doi: 10.1093/humrep/dew298. Epub 2016 Nov 16. Hum Reprod. 2017. PMID: 27852688
-
Can intracytoplasmic sperm injection prevent total fertilization failure and enhance embryo quality in patients with non-male factor infertility?Eur J Obstet Gynecol Reprod Biol. 2014 Jul;178:188-91. doi: 10.1016/j.ejogrb.2014.03.044. Epub 2014 Apr 13. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24793928
-
Surgically retrieved spermatozoa versus ejaculated spermatozoa in modified natural IVF-ICSI cycles.Reprod Biomed Online. 2012 Sep;25(3):242-7. doi: 10.1016/j.rbmo.2012.06.003. Epub 2012 Jun 19. Reprod Biomed Online. 2012. PMID: 22818097
-
Relationship between granular cytoplasm of oocytes and pregnancy outcome following intracytoplasmic sperm injection.Hum Reprod. 2000 Nov;15(11):2390-3. doi: 10.1093/humrep/15.11.2390. Hum Reprod. 2000. PMID: 11056140
-
Cumulus oophorus complexes favor physiologic selection of spermatozoa for intracytoplasmic sperm injection.Fertil Steril. 2018 May;109(5):823-831. doi: 10.1016/j.fertnstert.2017.12.026. Epub 2018 Mar 28. Fertil Steril. 2018. PMID: 29605408
Cited by
-
Oocyte Degeneration After ICSI Is Not an Indicator of Live Birth in Young Women.Front Endocrinol (Lausanne). 2021 Aug 16;12:705733. doi: 10.3389/fendo.2021.705733. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34484119 Free PMC article.
-
Are we Justified Doing Routine Intracytoplasmic Sperm Injection in Nonmale Factor Infertility? A Retrospective Study Comparing Reproductive Outcomes between In vitro Fertilization and Intracytoplasmic Sperm Injection in Nonmale Factor Infertility.J Hum Reprod Sci. 2019 Jul-Sep;12(3):210-215. doi: 10.4103/jhrs.JHRS_8_19. J Hum Reprod Sci. 2019. PMID: 31576078 Free PMC article.
-
The association of follicular fluid volume with human oolemma stretchability during intracytoplasmic sperm injection.Clin Exp Reprod Med. 2017 Sep;44(3):126-131. doi: 10.5653/cerm.2017.44.3.126. Epub 2017 Sep 26. Clin Exp Reprod Med. 2017. PMID: 29026718 Free PMC article.
-
Conventional in vitro fertilization maybe yields more available embryos than intracytoplasmic sperm injection for patients with no indications for ICSI.Int J Clin Exp Med. 2015 Nov 15;8(11):21593-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26885110 Free PMC article.
-
No advantage of laser-assisted over conventional intracytoplasmic sperm injection: a randomized controlled trial [NCT00114725].J Exp Clin Assist Reprod. 2006 Jul 5;3:5. doi: 10.1186/1743-1050-3-5. J Exp Clin Assist Reprod. 2006. PMID: 16822317 Free PMC article.
References
-
- Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340:17–18. - PubMed
-
- Dozortsev D, De Sutter P, Dhont M. Behaviour of spermatozoa in human oocytes displaying no or one pronucleus after intracytoplasmic sperm injection. Hum Reprod. 1994;9:2139–2144. - PubMed
-
- Dozortsev D, Rybouchkin A, De Sutter P, Dhont M. Sperm plasma membrane damage prior to intracytoplasmic sperm injection: A necessary condition for sperm nucleus decondensation. Hum Reprod. 1995;10:2960–2964. - PubMed
-
- Gerris J, Mangelschots K, Van Royen E, Joostens M, Eestermans W, Ryckaert G. ICSI and severe male-factor infertility: Breaking the sperm tail prior to injection. Hum Reprod. 1995;10:484–486. - PubMed
-
- Van den Bergh M, Bertrand E, Govaerts I, Koenig I, Biramane J, Englert Y. Preclinical trials for mastering intracytoplasmic injection of a sole spermatozoid for the treatment of male infertility. Contracept Fertil Sex. 1995;23:393–398. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources